- مبلغ: ۸۶,۰۰۰ تومان
- مبلغ: ۹۱,۰۰۰ تومان
Pediatric cardiomyopathies affect a small portion of the pediatric population, but the constellation of disorders encompasses a wide range of symptoms and disease severity. Medical and surgical therapies have continued to advance, and combined with increasing data from adult studies, cardiac rehabilitation likely has an important role in the care of these children as data shows benefits ranging from improved endothelial function to improved quality of life. While there are limited guidelines for exercise training and sports participation in children with cardiomyopathy, data to shape these guidelines remains sparse and the cardiomyopathy community is dependent upon expert opinions. Cardiac rehabilitation has been shown to be both feasible and safe although the studies are small and predominantly based on inpatient subjects with dilated cardiomyopathy which limits the applicability to other forms of cardiomyopathy and outpatient programs. Finally, multiple limitations exist to studying this area, but they are not insurmountable, and the evolution of technology may allow for innovative use of wearable technology to overcome some of these limitations.
Pediatric cardiomyopathies are a heterogeneous group of diseases but affect a small portion of the population. As such, data guiding the implementation and impact of cardiac rehabilitation on this population is strikingly limited. Despite this, few guidelines do exist, and they are based on expert opinion. There are likely multiple benefits of cardiac rehabilitation in this population, ranging from microscopic to psychological, although ongoing research is necessary to fully define these benefits. However, the benefits have to be weighed against the potential risks for each patient. Finally, the limited research provides an opportunity for multicenter collaboration, as well as the implementation of evolving technology to try to overcome the limitations identified.